Hormone-Peptide Conjugate: Next Generation Targeted Therapy
Time: 9:00 am
day: Conference Day 1
Details:
- Explore a paradigm shift in conjugate design, focusing on the mechanism rather than the molecule, to unlock new avenues for targeted therapy innovations
- Embrace innovation, this conjugate design bypasses traditional linker-based approaches, with the hormone directly fused to the lytic peptide, optimizing delivery and enhancing therapeutic efficacy
- Discover how the unique design of hormone-linked lytic peptides, leveraging electrostatic interactions for targeted cytotoxicity, offers a safer and more effective approach to cancer therapy
